Abstract Objective: Evidence is accumulating that components of the Cannabis sativa plant may have therapeutic potential in treating psychiatric disorders.…
Abstract There is international interest for consensus advice for prescribers working in the field of drug resistant epilepsy intending to…
Abstract Background: Cannabidiol (CBD) is the non-euphoriant component of cannabis. In 2017, the New Zealand Misuse of Drugs Regulations (1977)…
Abstract Background: Prescription practices, especially in South Asian countries, have come under investigation for quality. Although there have been no…